| Abbvie (3) |  |
| Alkaloid (11) | |
| Allergan (6) | |
| Astrazeneca (7) | |
| Basi (302) | |
| Bayer (10) | |
| Eisai company (3) | |
| Emergent biosolutions (4) | |
| F hoffmann la roche ltd (24) | |
| Glaxosmithkline (15) | |
| Merck & co (4) | |
| Novartis (22) | |
| Pfizer (10) | |
| Regeneron pharmaceuticals (3) | |
| Sanofi (5) | |
Odanacatib is produced by Merck & co. Inc. and has gone already through phase III clinical trials with good results Cao says.##
, GE, Genentech, Grace, Merck & co.,and Sartorius-Stedim was prompted by a $7. 9m grant from DARPA, the US Defense Advanced Research Projects Agency.
Merck & co.,, and Sartorius-Stedim was prompted by a $7. 9m grant from DARPA, the US Defense Advanced Research Projects Agency.
#Merck-Newlink Genetics Ebola Vaccine Shows 100%Efficacy in Phase III Trial Merck & co. and Newlink Genetics said today that a single dose of their Ebola vaccine candidate rvsv
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011